EARLY RESPONSE TO GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IN SHORT BOWEL SYNDROME PATIENTS WITH INTESTINAL FAILURE: RESULTS OF 24-WEEK PHASE 3 TRIAL

Tim Vanuytsel  1     Ulrich-Frank Pape  2     Sukanya Subramanian  3     Francisca Joly  4     Geert J.A. Wanten  5     Georg Lamprecht  6     Marek Kunecki  7     Faqooq Rahman  8     Thor Schutt Svane Nielsen  9     Lykke Bjerglund Graff  9     Mark Berner-Hansen  9     David F Mercer  10     Palle Bekker Jeppesen  11    
1 University Hospital, Leuven, Belgium
2 Asklepios Medical School, Berlin, Germany
3 MedStar Georgetown, Washington DC, United States
4 Hospital Beaujon, Clichy, France
5 Radboud University Nijmegen Medical Centre (Radboud UMCN), Nijmegen, Netherlands
6 University Medical Center Rostock, Rostock, Germany
7 M. Pirogow Hospital, Wolczanska, Poland
8 University College London Hospitals (UCLH), London, United Kingdom
9 Zealand Pharma A/S, Copenhagen, Denmark
10 Nebraska Medical Center, Nebraska, United States
11 Rigshospitalet, Copenhagen, Denmark

Topic
Hepatobiliary, IBD, Small Intestine & Nutrition

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing